tiprankstipranks
Trending News
More News >
Perspective Therapeutics (CATX)
:CATX
US Market

Perspective Therapeutics (CATX) Financial Statements

Compare
1,565 Followers

Perspective Therapeutics Financial Overview

Perspective Therapeutics's market cap is currently $201.46M. The company's EPS TTM is $-0.35; its P/E ratio is -1.86; Perspective Therapeutics is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-0.36. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 1.43M$ 7.10M$ 10.79M$ 10.05M
Gross Profit$ 0.00$ 1.43M$ 1.63M$ 4.62M$ 5.12M
Operating Income$ 10.46M$ -40.94M$ -15.18M$ -7.39M$ -3.44M
EBITDA$ 10.46M$ -39.96M$ -14.84M$ -7.39M$ -3.43M
Net Income$ -79.28M$ -46.51M$ -14.67M$ -7.15M$ -3.19M
Balance Sheet
Cash & Short-Term Investments$ 226.92M$ 9.24M$ 43.76M$ 60.35M$ 9.59M
Total Assets$ 341.10M$ 97.89M$ 58.09M$ 67.25M$ 15.51M
Total Debt$ 4.06M$ 2.55M$ 0.00$ 652.00K$ 897.00K
Net Debt$ -57.52M$ -6.69M$ -20.99M$ -59.70M$ -8.69M
Total Liabilities$ 50.43M$ 22.71M$ 3.45M$ 2.86M$ 2.74M
Stockholders' Equity$ 290.67M$ 75.18M$ 54.64M$ 64.39M$ 12.77M
Cash Flow
Free Cash Flow$ -72.71M$ -37.98M$ -12.47M$ -7.98M$ -3.22M
Operating Cash Flow$ -18.29M$ -36.91M$ -12.17M$ -7.71M$ -2.84M
Investing Cash Flow$ -218.93M$ 24.37M$ -57.68M$ -284.00K$ -410.00K
Financing Cash Flow$ 289.38M$ 785.00K$ 56.00K$ 56.00K$ 64.68M
Currency in USD

Perspective Therapeutics Earnings and Revenue History

Perspective Therapeutics Debt to Assets

Perspective Therapeutics Cash Flow

Perspective Therapeutics Forecast EPS vs Actual EPS